Search research articles
Contact Us
Filters
Showing results (161-170 of 273) with videos related to
Page
of 28
Sort By:
European Journal of Neurology
|
August 26, 2006
Task force guidelines handbook: EFNS guidelines on diagnosis and management of fatty acid mitochondrial disorders
C Angelini, A Federico, H Reichmann, et al.
Nucleic Acids Research
|
January 11, 1995
Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases
P Seibel, J Trappe, G Villani, et al.
Muscle & Nerve
|
December 1, 1993
Focal myositis of the temporal muscle
M Naumann, K V Toyka, H H Goebel, et al.
Neurogenetics
|
March 29, 2000
Adult-onset glycogen storage disease type II: phenotypic and allelic heterogeneity in German patients
M Vorgerd, B Burwinkel, H Reichmann, et al.
Journal of Neural Transmission. Supplementum
|
April 24, 2007
The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil
T Müller, J Welnic, G Fuchs, et al.
Der Nervenarzt
|
August 19, 2007
[Olfactory dysfunction in Parkinson's disease: its role as a new cardinal sign in early and differential diagnosis]
B Herting, S Bietenbeck, K Scholz, et al.
European Journal of Medical Research
|
July 28, 1997
Ophthalmoplegia plus: clinical relevance of magnetic resonance tomogaphy findings
A Lindner, D Georgiadis, E Hofmann, et al.
Biochemical and Biophysical Research Communications
|
October 28, 1994
Chronic progressive external ophthalmoplegia is associated with a novel mutation in the mitochondrial tRNA(Asn) gene
P Seibel, J Lauber, T Klopstock, et al.
Journal of Neural Transmission. Supplementum
|
April 24, 2007
Changing dopamine agonist treatment in Parkinson's disease: experiences with switching to pramipexole
H Reichmann, P Odin, H M Brecht, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 2, 2009
Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis
S Kern, W Schrempf, H Schneider, et al.
Page
of 28
Search research articles
Search
Showing results (161-170 of 273) with videos related to
Sort By:
Page
of 28
European Journal of Neurology
|
August 26, 2006
Task force guidelines handbook: EFNS guidelines on diagnosis and management of fatty acid mitochondrial disorders
C Angelini, A Federico, H Reichmann, et al.
Nucleic Acids Research
|
January 11, 1995
Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases
P Seibel, J Trappe, G Villani, et al.
Muscle & Nerve
|
December 1, 1993
Focal myositis of the temporal muscle
M Naumann, K V Toyka, H H Goebel, et al.
Neurogenetics
|
March 29, 2000
Adult-onset glycogen storage disease type II: phenotypic and allelic heterogeneity in German patients
M Vorgerd, B Burwinkel, H Reichmann, et al.
Journal of Neural Transmission. Supplementum
|
April 24, 2007
The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil
T Müller, J Welnic, G Fuchs, et al.
Der Nervenarzt
|
August 19, 2007
[Olfactory dysfunction in Parkinson's disease: its role as a new cardinal sign in early and differential diagnosis]
B Herting, S Bietenbeck, K Scholz, et al.
European Journal of Medical Research
|
July 28, 1997
Ophthalmoplegia plus: clinical relevance of magnetic resonance tomogaphy findings
A Lindner, D Georgiadis, E Hofmann, et al.
Biochemical and Biophysical Research Communications
|
October 28, 1994
Chronic progressive external ophthalmoplegia is associated with a novel mutation in the mitochondrial tRNA(Asn) gene
P Seibel, J Lauber, T Klopstock, et al.
Journal of Neural Transmission. Supplementum
|
April 24, 2007
Changing dopamine agonist treatment in Parkinson's disease: experiences with switching to pramipexole
H Reichmann, P Odin, H M Brecht, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 2, 2009
Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis
S Kern, W Schrempf, H Schneider, et al.
Page
of 28